We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance for Genetic Variation Discovery System

By Biotechdaily staff writers
Posted on 21 May 2002
A multiyear collaboration has been announced by the Max Planck Institute for Molecular Genetics (Berlin, Germany) and Transgenomic, Inc. More...
(Omaha, NE, USA) for the development of a system for high-throughput genetic variation discovery.

Funded by the German National Genome Research Network and incorporating Transgenomic technology, the system developed will provide researchers with a better tool to attack large-scale genetic variation studies. These are essential for developing associations between genetic variation and diseases, which will allow biopharmaceutical companies to develop diagnostic tools and gene-based therapies, says Transgenomic. The work is to be performed in the department of Prof. Hans Lehrach of the Max Planck Institute.

"The Transgenomic technology should contribute to an eloquent solution for the high-throughput analysis needs, not only by its function but also by its economical nature,” said Dr. Lehrach, director of the department of vertebrate genomics.





Related Links:
Transgenomic
Max Planck Inst.

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Multi-Chamber Washer-Disinfector
WD 390
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.